The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions
about
An integrated approach to elucidate the intra-viral and viral-cellular protein interaction networks of a gamma-herpesvirusHuman herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cellsHuman herpesvirus 8--a novel human pathogenKSHV Genome Replication and MaintenanceThe Role of Gammaherpesviruses in Cancer PathogenesisThe modulation of apoptosis by oncogenic virusesKSHV: pathways to tumorigenesis and persistent infectionComprehensive analysis of LANA interacting proteins essential for viral genome tethering and persistenceLytic replication of Kaposi's sarcoma-associated herpesvirus results in the formation of multiple capsid species: isolation and molecular characterization of A, B, and C capsids from a gammaherpesvirus.Three-dimensional structures of the A, B, and C capsids of rhesus monkey rhadinovirus: insights into gammaherpesvirus capsid assembly, maturation, and DNA packaging.Capsid structure of Kaposi's sarcoma-associated herpesvirus, a gammaherpesvirus, compared to those of an alphaherpesvirus, herpes simplex virus type 1, and a betaherpesvirus, cytomegalovirusHost transcript accumulation during lytic KSHV infection reveals several classes of host responsesHIV-1 Tat and AIDS-associated cancer: targeting the cellular anti-cancer barrier?Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma.Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infected mice.Glycyrrhizic acid alters Kaposi sarcoma-associated herpesvirus latency, triggering p53-mediated apoptosis in transformed B lymphocytes.KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.Characterization of the minimal replicator of Kaposi's sarcoma-associated herpesvirus latent origin.A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirusDistinct biology of Kaposi's sarcoma-associated herpesvirus from primary lesions and body cavity lymphomas.Three-dimensional structure of the human herpesvirus 8 capsid.Expression of the open reading frame 74 (G-protein-coupled receptor) gene of Kaposi's sarcoma (KS)-associated herpesvirus: implications for KS pathogenesisHuman immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-associated herpesvirusModulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA.Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes.Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseasesCharacterization of the Kaposi's sarcoma-associated herpesvirus K1 signalosome.Viral latency and its regulation: lessons from the gamma-herpesviruses.Identification of properties of the Kaposi's sarcoma-associated herpesvirus latent origin of replication that are essential for the efficient establishment and maintenance of intact plasmids.Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1)Single molecule analysis of replicated DNA reveals the usage of multiple KSHV genome regions for latent replication.A systems biology approach identified different regulatory networks targeted by KSHV miR-K12-11 in B cells and endothelial cellsPatterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirusImmune escape of γ-herpesviruses from adaptive immunityFunctional analysis of Kaposi's sarcoma-associated herpesvirus vFLIP expression reveals a new mode of IRES-mediated translation.Messenger RNA sequence rather than protein sequence determines the level of self-synthesis and antigen presentation of the EBV-encoded antigen, EBNA1.The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 N terminus is essential for chromosome association, DNA replication, and episome persistenceAcetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription.Kaposi's sarcoma-associated herpesvirus-encoded replication and transcription activator impairs innate immunity via ubiquitin-mediated degradation of myeloid differentiation factor 88
P2860
Q24294710-8BDD8A0F-2F4E-43C1-817A-5F6B2B4B0B1FQ24527215-6C46F486-6DD1-4F07-BC21-8EF4D6DE5E60Q24530670-E2BF7721-A643-4E75-AAE2-0516683A5A62Q26766437-A1753D57-BC0A-4C89-BFD4-17922E2F1274Q26767186-060EB500-A83E-4391-AFFA-3F284D1048D1Q26995410-321E3199-59DC-4B70-BBA5-1F0200B1CB19Q27026000-8674B953-E1D7-42B8-9F3B-84C5BD84B87BQ28533244-8AF281AB-0B2D-4ADE-82AA-A470DFE73DFBQ30306907-FC1CB858-4D00-4A7C-A205-BDCF72783DCAQ30450951-4D28F529-8C69-4C5A-AD91-4248B85381C6Q30453457-F3D41E9F-F2BF-4A1D-BBA0-1FE2A434A453Q33295395-16042284-791D-424C-B36E-DB32D17261F8Q33346504-80EB58AB-23FC-4D82-A440-E707D626267DQ33432690-0C3420E2-2CB6-4A4E-A8D0-44788D9B2952Q33653581-8A22FC11-E991-4177-BEA7-C7E05CB10E23Q33683742-53A81BDD-4CBC-4F7B-A123-BEAA1CB33CA1Q33761091-188D08FE-C3E6-4E23-A020-09D32679702CQ33781363-BF878389-E5D3-4CAB-AC58-4B5DAC965767Q33784966-48E35718-ED4B-4B48-A5B1-506C1FDAFF6BQ33786189-8E94B320-1D15-43EA-AB66-CC7EF03CC3F9Q33811735-76EA6158-F0A2-4C91-9D86-7FED05FB6ED5Q33815875-E5A1582C-99F1-413E-B3B5-12B0B6A75BA1Q33825453-AFDA2BC8-22EF-4754-BF2B-14F19FC9B27DQ33835021-E8699C3C-E7F3-41EA-A6EA-C32A8A051A4CQ33838228-3E055F73-619F-4E0C-8850-C89B65F54F9EQ33851443-7A9632AD-AEC6-4CC4-B969-B33DD91D9C65Q33906970-F4EAA2F3-0C45-457F-8532-53DB373B40D2Q33984196-F6B9DA39-71F8-47B8-A07D-6880F75711B9Q34039189-14FC3810-C5B9-451B-AC4F-7F4477C5B9EEQ34057984-7A1F09DD-A518-46EA-ABF0-71CE27145D25Q34069105-DA424234-EA2C-4605-90CF-D2FA6CD1E61FQ34071388-5D07267F-DAA8-4C88-AA70-A35A5622168CQ34100180-9BFFC231-82BC-4A8D-A3E7-A8A1048213B2Q34333321-8509199F-3797-4AC1-A329-B1BA9F6718F3Q34345549-7A083188-4140-4944-9331-295EC9815577Q34363927-932329A2-9D40-4F04-9D18-46CA1FF958EDQ34539792-69527E08-FFCC-4E17-A7DF-A141669F5DB6Q34553975-67F1B25D-F429-46DA-802B-553B69339215Q34648229-BBE6870F-1F65-4A08-89A5-FCEE1CFF3423Q34992629-835B4B5B-61E3-473E-A85B-A1A395C15A88
P2860
The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
The size and conformation of K ...... in infected cells and virions
@en
The size and conformation of Kaposi's sarcoma-associated herpesvirus
@nl
type
label
The size and conformation of K ...... in infected cells and virions
@en
The size and conformation of Kaposi's sarcoma-associated herpesvirus
@nl
prefLabel
The size and conformation of K ...... in infected cells and virions
@en
The size and conformation of Kaposi's sarcoma-associated herpesvirus
@nl
P2093
P2860
P1433
P1476
The size and conformation of K ...... in infected cells and virions
@en
P2093
P2860
P304
P407
P50
P577
1996-11-01T00:00:00Z